ConcertAI

ConcertAI is a leader in generative and agentic AI solutions purpose-built for life sciences and healthcare organizations. The company combines advanced artificial intelligence with deep, multi-modal real-world data (RWD) to accelerate translational medicine, clinical development, oncology care, imaging and diagnostics, and commercial strategy. ConcertAI serves both life science enterprises — including pharmaceutical sponsors and biotech companies — and healthcare providers seeking to improve patient outcomes and streamline clinical operations.

At the core of ConcertAI's platform is CARAai™, its proprietary AI engine, paired with one of the industry's most comprehensive integrated oncology datasets. Together, these capabilities power a growing suite of products that unify real-world data, AI innovation, and clinical expertise to drive breakthroughs across the full spectrum of drug discovery, development, and delivery.

PRECISIONSUITE — AI + RWD Solutions for the Life Science Enterprise

• PrecisionExplorer™ — A generative AI tool designed for real-world evidence analysis, enabling life science teams to extract meaningful insights from complex oncology datasets rapidly and at scale.
• PrecisionTRIALS™ — An AI-powered solution that supports smarter, faster decision-making for clinical trial success, helping sponsors improve study timelines and reduce trial risk.
• PrecisionGTM™ — An AI-driven go-to-market intelligence tool that delivers actionable insights for oncology commercial strategy and market planning.
• Precision360™ — A data-accelerated solution focused on oncology research, providing comprehensive analytical capabilities across the cancer care continuum.

Core Product Lines and Capabilities

• Real World Evidence — Comprehensive, oncology-focused data and services that help life science organizations better understand the therapy landscape and generate evidence to support drug development and regulatory decisions.
• Accelerated Clinical Trials — Solutions that enable sponsors to de-risk and accelerate clinical trials through improved study timelines and more effective patient recruitment strategies.
• Commercial Solutions — Patient-centric data aggregation and AI-driven assistants designed to optimize patient outcomes and drive brand success for life sciences commercial teams.
• CancerLinQ® — A clinical insights platform that delivers real-time data, quality measure tracking, and trial screening support to improve cancer care delivery for healthcare providers. The SmartLinQ™ module provides real-time clinical insights at the point of care.
• TeraRecon — AI-powered medical imaging interpretation software that reduces cognitive burden and enhances decision-making for healthcare providers through advanced AI visualization tools.

Real-World Data Assets

• Coverage of more than 11 million unique patients across all 50 U.S. states with exceptional geographic breadth.
• Data sourced from more than 900 cancer center locations, providing deep oncology-specific clinical detail.
• Includes more than 200 clinically relevant biomarkers, enabling precise molecular and genomic analysis to support translational research and drug development.
• Multi-modal data assets span structured and unstructured clinical records, genomic data, imaging, and more.

Key Partnerships and Integrations

• ConcertAI has formed an alliance with NVIDIA to build AI agents specifically designed for oncology clinical trials, accelerating the application of agentic AI in drug development.
• ConcertAI has integrated with Foundation Medicine to combine genomic and clinical data, transforming translational research and enabling more efficient drug development workflows.
• The company maintains relationships with a broad network of life science clients — including pharmaceutical and biotech sponsors — as well as healthcare provider organizations across the United States.

Research and Thought Leadership

• ConcertAI actively publishes real-world evidence studies at major medical conferences, including the ASCO Annual Meeting, covering therapeutic areas such as metastatic prostate cancer, metastatic colorectal cancer, and other oncology indications.
• The company produces a broad range of resources including research publications, case studies, product updates, podcasts, and thought leadership content focused on AI innovation in healthcare and life sciences.

From discovery to delivery, ConcertAI's integrated platform of AI products, real-world oncology data, and clinical expertise positions it as a strategic partner for life sciences and healthcare organizations seeking to accelerate research, improve trial efficiency, and ultimately enhance patient outcomes across oncology and beyond.